Literature DB >> 25012805

Can we identify risk factors during pregnancy for thrombo-embolic events during the puerperium and later in life?

Maor Waldman1, Eyal Sheiner, Ruslan Sergienko, Ilana Shoham-Vardi.   

Abstract

OBJECTIVES: To investigate parturients at risk to develop venous thrombo-embolic events (VTE) in the puerperium or later in life, during a follow-up of more than a decade and compare risk factors for VTE during the puerperium with VTE later in life.
METHODS: A nested case-control study was conducted to profile parturients at risk for VTE and a secondary analysis to compare risk factors for VTE during or after puerperium. We used a cohort of 95 257 women who gave birth between the years 1988 and 1998.
RESULTS: Independent risk factors to develop VTE were peripartum hysterectomy, stillbirth, cesarean delivery (CD), obesity, pregnancy-related hypertension, grandmultiparity and advanced maternal age. Women undergoing CD and those receiving blood transfusion were more likely to develop early versus late VTE (OR = 2.0, 95% CI = 1.15-3.5 and OR = 11.0, 95% CI = 2.25-55.5; respectively). Patients that encountered VTE during the puerperium had more pulmonary emboli and less deep vein thrombosis, compared with the late VTE group (p < 0.001).
CONCLUSIONS: Maternal age, grandmultiparity, pregnancy-related hypertension, CD, obesity, stillbirth and peripartum hysterectomy are independent risk factors for the development of VTE. CD and blood transfusion were predictive of early versus late VTE.

Entities:  

Keywords:  Pregnancy; puerperium; risk factors; thrombo-embolic events

Mesh:

Year:  2014        PMID: 25012805     DOI: 10.3109/14767058.2014.944155

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Deep venous thrombosis in a patient undergoing In-vitro fertilization with oocyte donation.

Authors:  Nalini Mahajan; Padmaja Naidu; Shalu Gupta; Kumkum Rani
Journal:  J Hum Reprod Sci       Date:  2015 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.